t2dm presentation (1)

24
Date April 8, 2013 Type 2 Diabetes Group 2

Upload: aeber5192

Post on 14-Apr-2018

226 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 1/24

Date April 8, 2013

Type 2 DiabetesGroup 2

Page 2: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 2/24

Obesity: It’s a BIG problem

Page 3: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 3/24

Type 2 Diabetes

β cell dysfunction and insulin resistance

High levels of circulating glucose

Increased risk for other health concerns

Treatments:

Weight loss and introduction of physical activity

Link to Vitamin D deficiency

Link to Magnesium Deficiency

Page 4: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 4/24

Vitamin D Introduction

Several past studies have shown a correlation between T2DM andvitamin D deficiency

Vitamin D has been seen to play a functional role in glucose tolerancethrough its effect on both (1) insulin secretion and (2) insulinsensitivity.

Both T2DM and vitamin D deficiency share common risk factors

including race, obesity, aging and low physical activity

This study observes the supplementation effect vitamin D has on

insulin resistance in T2DM.

Why study vitamin D?

What is the objective?

Page 5: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 5/24

Methods of Research

Single blind, 100 participants with T2DM, aging 30-70 years old

Gathered physiological levels in order to have all participantsassessed at baseline

Participant’s diet and medicine intake was unchanged throughout theduration of the study

50,000 units of D3 were given weekly for 2 months

Physiological levels were assessed again in order to determine results

Page 6: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 6/24

Results

Table 1 Comparison of biochemical characteristics (mean± SD) inpatients with diabetes type 2 before and after treatment with vitamin Dfor 8 weeks

 Variable Before treatment After treatment P-value

FPG(mg/dl) 138.48±36.74 131.02±39 0.05

(mmol/l)  7.6±2.04 7.27±2.16

Insulin(μIu/ml)  10.76±8.9 8.6±8.25 0.02

HOMA-IR  3.57±3.18 2.89±3.28 0.008

25(OH)D (ng/ml) 43.03±19.28 60.12±17.2 0.02

(nmol/l) 107.5±48.2 150.3±43

Page 7: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 7/24

Results

Table 3 Comparison of lipid profile in patients with diabetes type 2before and after treatment with vitamin D (mean± SD) for 8 weeks

 Variable (mg/dl) Before treatment After treatment P-value

T-COL  191.1±32.2 180.2±31.0 0.3

TAG  234.4±73.3 201.0±65.1 0.2

LDL-C  109.5±26.4 103.0±23.2 0.5

HDL-C 42.5±8.1 38.2±7.2 0.3

Page 8: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 8/24

Vitamin D Supplementation Effects

Mechanisms:

Presence of vitamin D receptors on pancreatic β cells 

Calcium is increased due to vitamin D intake leading to glucosetransporting to the muscle

Presence of vitamin D response element in the insulin gene 

Insulin resistance significantly affected by vitamin D (in concentrations between 40-60 ng/ml)

Glucose homeostasis: insulin resistance decreased with vitamin Dsupplementation

Page 9: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 9/24

Mechanism

Figure 1

Page 10: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 10/24

Limitations

Study did not evaluate the effects of placebo on FPG, insulin, or HOMA-IR

Small sample size (100 participants)

The dietary intake among the individuals may vary

Page 11: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 11/24

Magnesium Methods

2 Studies Included in the Research:

Nurse’s Health Study (NHS)

Healthy Professional’s Follow-Up Study (HPFS)

Both Updated Every 2 Years

Persons Excluded From Study:

History of CVD, Diabetes, & Cancer 

 After Exclusions For Present Analysis:

85,060 Women Followed Over 18 Years

42,872 Men Followed Over 12 Years

Page 12: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 12/24

Magnesium Methods

Food Frequency Questionnaire (FFQ)

Common Unit/Portion Size Estimated for Each Food

Nutrient Intake Computed by Multiplying the Frequency of Consumptionx Nutrient Content of Specified Portions

Other Factors Measured:

Magnesium Supplementation

Measurement of Non-Dietary Factors

Page 13: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 13/24

Magnesium Methods

 Ascertainment of Diabetes:

Survey given every 2 years to determine if subject had been diagnosed withDiabetes

Subjects had to meet the following criteria to be considered diabetic:

Elevated Plasma Glucose (>140mg/dl)

Elevated Plasma Glucose in Absence of Symptoms

Treatment with Hypoglycemic Therapy (Insulin or Oral Hypoglycemic Agents 

Page 14: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 14/24

Magnesium Methods

Statistical Data:

Participants divided into quintiles of total Magnesium intake

Relative risk computed as incidence rate of diabetes in each quintile/incidence rate in lowest quintile of intake

Likelihood ratio x² used to assess significance of interactions between Magnesium intake and variables used

 Adjusted Variables:

BMI

Family History

Smoking History

 Alcohol intake

Diet

Page 15: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 15/24

Results

 An inverse association seen between Mg intake and type 2 diabetesrisk

Relative risk (RR) for type 2 diabetes was 0.66 (P>.001) in womenand 0.67 (P>.001) in men in highest Mg intake groups compared tolowest

Result still significant when adjusted for confounding factors

Findings support dietary recommendation of increased consumptionof foods high in Mg

Page 16: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 16/24

Results

Page 17: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 17/24

Results - discussion

Results consistent with other experimentalstudies showing protective role of Mgagainst diabetes

cofactor role of Mg in carbmetabolism

tyrosine-kinase in insulinpostreceptor pathway in muscle

cell

Limitations:

self-reporting

initial health differences

Page 18: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 18/24

Conclusion

Vitamin D

Vitamin D supplementation results in

significant improvements in serum FPG,

insulin and in HOMA-IR thus reducinginsulin resistance in T2DM.

Magnesium

Diets high in magnesium rich foods

reduce risk of T2DM due to an inverse

association between magnesium intakeand diabetes risk.

Page 19: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 19/24

Conclusion

Both studies supportthe originalhypotheses thatvitamin D andmagnesium

correlation with type2 diabetes

Confirmed 

Page 20: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 20/24

Mechanism: Magnesium

Page 21: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 21/24

Mechanism: Vitamin D

Page 22: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 22/24

Future Studies

Vitamin D

-Placebo group on FPG, insulin, or HOMA-IR

-Larger sample size

Magnesium

-Medical professionals confirm diagnosis

vs. self-diagnosis

-Randomized clinical trials

-Utilized same time frame

Page 23: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 23/24

Other Prevention Methods andTreatments

Prevention: Healthy Lifestyle 

Diet

Exercise 

Treatments:

Oral medications (Metformin)

Insulin injections

Bariatric surgery

Biotin

Chromium

Zinc

 Aloe Vera Gel

Page 24: T2DM Presentation (1)

7/27/2019 T2DM Presentation (1)

http://slidepdf.com/reader/full/t2dm-presentation-1 24/24

Questions?